These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30689472)

  • 1. Introducing new vaccines in low- and middle-income countries: challenges and approaches.
    Guignard A; Praet N; Jusot V; Bakker M; Baril L
    Expert Rev Vaccines; 2019 Feb; 18(2):119-131. PubMed ID: 30689472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?
    Giersing BK; Kahn AL; Jarrahian C; Mvundura M; Rodriguez C; Okayasu H; Zehrung D
    Vaccine; 2017 Dec; 35(49 Pt A):6793-6797. PubMed ID: 28566254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.
    Wang SA; Hyde TB; Mounier-Jack S; Brenzel L; Favin M; Gordon WS; Shearer JC; Mantel CF; Arora N; Durrheim D
    Vaccine; 2013 Apr; 31 Suppl 2(0 2):B122-8. PubMed ID: 23598473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strategies: Optimising outcomes.
    Hardt K; Bonanni P; King S; Santos JI; El-Hodhod M; Zimet GD; Preiss S
    Vaccine; 2016 Dec; 34(52):6691-6699. PubMed ID: 27887796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redefining vaccination coverage and timeliness measures using electronic immunization registry data in low- and middle-income countries.
    Dolan SB; Carnahan E; Shearer JC; Beylerian EN; Thompson J; Gilbert SS; Werner L; Ryman TK
    Vaccine; 2019 Mar; 37(13):1859-1867. PubMed ID: 30808566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving immunization capacity in Ethiopia through continuous quality improvement interventions: a prospective quasi-experimental study.
    Manyazewal T; Mekonnen A; Demelew T; Mengestu S; Abdu Y; Mammo D; Abebe W; Haffa B; Zenebe D; Worku B; Aman A; Tigabu S
    Infect Dis Poverty; 2018 Nov; 7(1):119. PubMed ID: 30497515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
    Peyraud N; Zehrung D; Jarrahian C; Frivold C; Orubu T; Giersing B
    Vaccine; 2019 Jul; 37(32):4427-4434. PubMed ID: 31262587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal interventions vigilance harmonization in low- and middle-income countries: Stakeholder meeting report; Amsterdam, May 1-2, 2018.
    Sobanjo-Ter Meulen A; Munoz FM; Kaslow DC; Klugman KP; Omer SB; Vora P; Stergachis A
    Vaccine; 2019 May; 37(20):2643-2650. PubMed ID: 30955981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
    Moro PL; Haber P; McNeil MM
    Expert Rev Vaccines; 2019 Oct; 18(10):1091-1101. PubMed ID: 31580725
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
    Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O
    Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review.
    Gerste AK; Majidulla A; Baidya A; Georgewill O; DeLuca AN; Pelzer PT; Gill MM; Jerene D; Buis JS; Kerkhoff AD; Limaye RJ
    Expert Rev Vaccines; 2024; 23(1):688-704. PubMed ID: 38967117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicating vaccine safety in the context of immunization programs in low resource settings.
    Arwanire EM; Mbabazi W; Mugyenyi P
    Curr Drug Saf; 2015; 10(1):68-75. PubMed ID: 25859678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing new vaccines in developing countries.
    Kochhar S; Rath B; Seeber LD; Rundblad G; Khamesipour A; Ali M;
    Expert Rev Vaccines; 2013 Dec; 12(12):1465-78. PubMed ID: 24195483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of new vaccine introduction on immunization and health systems: a review of the published literature.
    Hyde TB; Dentz H; Wang SA; Burchett HE; Mounier-Jack S; Mantel CF;
    Vaccine; 2012 Oct; 30(45):6347-58. PubMed ID: 22940378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations.
    Kochhar S; Edwards KM; Ropero Alvarez AM; Moro PL; Ortiz JR
    Vaccine; 2019 May; 37(25):3267-3277. PubMed ID: 31072733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.